Все публикации

0:32:57

Session 9: Industry panel session

0:59:44

Session 10: Clinician and patient panel session

0:23:55

Session 8: Duchenne UK's Focus in Research and Development

0:41:04

Lunch breakout session: Education

0:40:53

Session 6: Other therapeutic approaches

0:36:58

Session 7: Pre-clinical developments

0:51:36

Session 5: Dystrophin replacement therapies

0:43:41

Session 4: Treating DMD

0:25:21

Session 3: DMD Care UK - Nutrition

0:46:03

Session 2: DMD Care UK - Psychosocial care

1:00:57

Session 1: DMD Care UK - Good care saves lives

0:02:23

New Horizons 2024

0:01:18

Sign up for the Dash 2025!

0:04:13

Duchenne Dash 2024 look back video

0:00:45

Why we're doing the Duchenne Dash 2024

0:04:11

Fundraising tips for your Duchenne Dash

0:08:02

CEO and co-founder, Emily Reuben OBE, speaks to Professor Volker Straub about DMD research prospects

0:05:37

CEO and co-founder, Emily Reuben OBE, speaks to Dr Annemieke Aartsma-Rus about exon skipping for DMD

0:04:33

CEO and co-founder, Emily Reuben OBE, speaks to Professor John Bourke about DMD and the heart

0:03:51

CEO and co-founder, Emily Reuben OBE, speaks to Professor Kay Davies about current DMD research

0:06:15

CEO and co-founder, Emily Reuben OBE, speaks to Dr Barry Byrne about gene therapy for DMD

0:01:17

Why we ride for Duchenne UK

0:39:12

Webinar to discuss EMBARK trial of gene therapy delandistrogene moxeparvovec to treat DMD

0:03:06

Register for a place on the Duchenne Dash 2024